Clinical Trials Market by Phase (Phase I, II, III), Service Type (Laboratory, Analytical Testing, Patient Recruitment, Protocol Designing), Therapeutic Area (Oncology, Cardiology, Neurology), and Application (Vaccine, mAbs, CGT) - Global Forecast to 2028

Clinical Trials Market by Phase (Phase I, II, III), Service Type (Laboratory, Analytical Testing, Patient Recruitment, Protocol Designing), Therapeutic Area (Oncology, Cardiology, Neurology), and Application (Vaccine, mAbs, CGT) - Global Forecast to 2028



The global clinical trials market is projected to reach USD 73.2 billion by 2028 from USD 48.2 billion in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the increasing demand for specialized testing services. Companies are increasingly outsourcing specialized testing services, such as liquid chromatography-mass spectrometry (LC/MS), RNA sequencing, gene expression analysis, wet chemistry analysis of compendia raw materials, and trace metal analysis with inductively coupled mass spectrometry (ICP-MS). These tests require advanced equipment and skilled professionals. In an effort to reduce equipment and labor expenses, pharmaceutical and biopharmaceutical enterprises prefer the outsourcing of these specialized testing services to Contract Research Organizations (CROs).

“The small molecules segment accounted for the largest share by application in 2022.”

In 2022, the small molecules segment accounted for the largest share by application in the global clinical trials market. Small molecules cover a wide spectrum of therapeutic areas, from cardiovascular diseases to infectious diseases to cancer. This versatility allows for a diverse range of clinical trials across different medical conditions. The development process for small molecules is well-established and understood by regulatory agencies like the US FDA. This familiarity expedites the approval process and encourages pharmaceutical companies to invest in clinical trials for these compounds. These factors contributed to the dominance of the segment in 2022.

“The US has continued to dominate the clinical trials market during the forecast period of 2023-2028.”

The US dominated the clinical trials market in North America in 2022. The major share of the US clinical trials market can be attributed to the significant number of clinical trials and drug discovery activities conducted in the country, coupled with the presence of state-of-the-art research and development infrastructure within the pharmaceutical and biopharmaceutical sectors. The US serves as a global hub for clinical trials, with a significant portion of drug development research being carried out in the US. This trend is attributed to its robust regulatory framework and highly advanced hospital infrastructure. According to ClinicalTrials.gov, as of August 2023, the global count of registered clinical studies reached 463,610. Notably, one-third of this total, accounting for 165,148 registered clinical studies, were concluded within the US.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 40% and Demand Side 60%

By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%

By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

IQVIA Inc. (US)

Laboratory Corporation of America Holdings (US)

Syneos Health (US)

WuXi AppTec (China)

Charles River Laboratories (US)

Parexel International Corporation (US)

Thermo Fisher Scientific Inc. (US)

ICON plc (Ireland)

Medpace (US)

ACM Global Laboratories (US)

Advanced Clinical (US)

SGS (Switzerland)

Frontage Labs (US)

PSI (Switzerland)

Bioagile (India)

Fortrea Inc. (US)

Clinical Trial Service (Netherlands)

Worldwide Clinical Trials (US)

Pepgra (UK)

CTI Clinical Trial & Consulting (US)

Dove Quality Solutions (UK)

Firma Clinical Research (US)

Celerion (US)

Novotech (Australia)

Clinical Americas (Japan)

Research Coverage:

This research report categorizes the clinical trials market by phase (Phase III, Phase II, Phase IV, and Phase I), by Service Type (Laboratory Services, Bioanalytical Testing Services, Decentralized Clinical Trial Services, Patient Recruitment, Site Identification, Analytical Testing Services, Clinical Trial Supply & Logistic Services, Protocol Designing, Clinical Trial Data Management Services, Medical Device Testing Services, and Other Services), by Therapeutic Area (Oncology, Infectious Diseases, Neurology, Metabolic Disorders, Immunology, Cardiology, Genetic Diseases, Women's Health, and Others) by Application (Small Molecules, Monoclonal Antibodies, Vaccine, Cell & Gene Therapy, and Others) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, trends, challenges, and opportunities, influencing the growth of the clinical trials market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services, key strategies, collaborations, partnerships, and agreements. New launches, mergers and acquisitions, and recent developments associated with the clinical trials market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall clinical trials market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Increasing drugs in the pipeline, rising investments in pharmaceutical R&D, and increasing number of clinical trials), restraints (Shortage of skilled professionals for clinical trials, Need for unique testing approaches for innovative molecules), opportunities (Favorable outlook for biologics and biosimilars and Rising demand for specialized testing services), and Trends (Adoption of AI-based tools for drug discovery) influencing the growth of the market.

Service Development/Innovation: Detailed insights on newly launched services of the clinical trials market

Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.

Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the clinical trials market

Competitive Assessment: In- IQVIA Inc. (US), Laboratory Corporation of America Holdings (US), Syneos Health (US), WuXi AppTec (China), Charles River Laboratories (US), Parexel International Corporation (US), Thermo Fisher Scientific Inc. (US), ICON plc (Ireland), Medpace (US), ACM Global Laboratories (US), Advanced Clinical (US), SGS (Switzerland), Frontage Labs (US), PSI (Switzerland), Bioagile (India), Fortrea Inc. (US), and among others in the market.


  • INTRODUCTION
    • STUDY OBJECTIVES
    • MARKET DEFINITION
      • INCLUSIONS AND EXCLUSIONS
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED
      • CURRENCY CONSIDERED
    • LIMITATIONS
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
      • RECESSION IMPACT
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • INSIGHTS FROM PRIMARIES
      • SEGMENT ASSESSMENT (BY PHASE, SERVICE TYPE, THERAPEUTIC AREA, AND APPLICATION)
      • SEGMENT ASSESSMENT (BY PHASE, SERVICE TYPE, AND THERAPEUTIC AREA)
    • GROWTH FORECAST
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS
    • RISK ANALYSIS
    • CLINICAL TRIALS MARKET: RECESSION IMPACT ANALYSIS
      • Table GLOBAL INFLATION RATE PROJECTIONS, 2021-2028 (% GROWTH)
      • Table US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
      • Table US HEALTH EXPENDITURE, 2023-2030 (USD MILLION)
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • CLINICAL TRIALS MARKET OVERVIEW
    • NORTH AMERICA: CLINICAL TRIALS MARKET SHARE, BY PHASE & COUNTRY (2022)
    • BIOANALYTICAL SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD BILLION)
    • CLINICAL TRIALS MARKET SHARE, BY THERAPEUTIC AREA, 2023-2028
    • CLINICAL TRIALS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • Table CLINICAL TRIALS MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
      • DRIVERS
      • OPPORTUNITIES
        • Table LIST OF BIOLOGICS APPROVED BY US FDA, 2022
      • CHALLENGES
      • TRENDS
    • TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
    • VALUE CHAIN ANALYSIS
    • INDICATIVE PRICING ANALYSIS
      • Table PHASE 3 ONCOLOGY CLINICAL TRIAL COST (US AND EUROPEAN COUNTRIES)
      • Table PHASE I ONCOLOGY CLINICAL TRIAL COST (SPAIN-EUROPE)
    • ECOSYSTEM ANALYSIS
      • Table OVERALL MARKET ECOSYSTEM FOR CLINICAL TRIALS
    • TECHNOLOGY ANALYSIS
    • PORTER’S FIVE FORCES ANALYSIS
      • Table CLINICAL TRIALS MARKET: PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • DEGREE OF COMPETITION
    • REGULATORY ANALYSIS
      • REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table CLINICAL TRIALS MARKET REGULATORY SCENARIO, BY COUNTRY/REGION
    • KEY CONFERENCES AND EVENTS (2023-2024)
      • Table CLINICAL TRIALS MARKET: DETAILED LIST OF CONFERENCES & EVENTS (2023-2024)
    • KEY STAKEHOLDERS & BUYING CRITERIA
      • KEY STAKEHOLDERS IN BUYING PROCESS
      • BUYING CRITERIA FOR CLINICAL TRIALS
  • CLINICAL TRIALS MARKET, BY PHASE
    • INTRODUCTION
      • Table CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
    • PHASE III
      • RISING PRICES OF PHASE III TRIALS TO DRIVE DEMAND FOR COST - EFFECTIVE CLINICAL RESEARCH SERVICES
        • Table OVERVIEW OF DRUGS THAT HAVE COMPLETED PHASE III (2021-2022)
        • Table PHASE III CLINICAL TRIALS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHASE III CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHASE III CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHASE III CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • PHASE II
      • LONG DURATION OF PHASE II STUDIES TO PROVIDE GROWTH OPPORTUNITIES FOR CROS
        • Table OVERVIEW OF DRUGS THAT HAVE COMPLETED PHASE II (2021-2022)
        • Table PHASE II CLINICAL TRIALS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHASE II CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHASE II CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHASE II CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • PHASE IV
      • RISING NUMBER OF CLINICAL RESEARCH ENTITIES PROVIDING POST-MARKETING SURVEILLANCE TO DRIVE MARKET
        • Table OVERVIEW OF DRUGS THAT HAVE COMPLETED PHASE IV (2021-2022)
        • Table PHASE IV CLINICAL TRIALS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHASE IV CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHASE IV CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHASE IV CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • PHASE I
      • ROBUST PIPELINE OF PHARMACEUTICAL COMPANIES TO BOOST MARKET
        • Table OVERVIEW OF DRUGS IN PHASE I STUDIES (2021-2022)
        • Table PHASE I CLINICAL TRIALS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PHASE I CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PHASE I CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PHASE I CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • CLINICAL TRIALS MARKET, BY SERVICE TYPE
    • INTRODUCTION
      • Table CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • LABORATORY SERVICES
      • RISING IMPORTANCE OF LAB SERVICES AND NEED TO ENSURE REGULATORY COMPLIANCE TO DRIVE MARKET
        • Table LABORATORY SERVICES OFFERED BY PROMINENT PLAYERS
        • Table LABORATORY SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: LABORATORY SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: LABORATORY SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: LABORATORY SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • BIOANALYTICAL TESTING SERVICES
      • Table BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
      • Table BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • CELL-BASED ASSAYS
        • Table CELL-BASED ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • VIROLOGY TESTING
        • Table VIROLOGY TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: VIROLOGY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: VIROLOGY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: VIROLOGY TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES
        • Table SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • PK/PD TESTING
        • Table PK/PD TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PK/PD TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PK/PD TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PK/PD TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • METHOD DEVELOPMENT, OPTIMIZATION, AND VALIDATION
        • Table METHOD DEVELOPMENT, OPTIMIZATION, AND VALIDATION MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: METHOD DEVELOPMENT, OPTIMIZATION, AND VALIDATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: METHOD DEVELOPMENT, OPTIMIZATION, AND VALIDATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: METHOD DEVELOPMENT, OPTIMIZATION, AND VALIDATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • BIOMARKER TESTING
        • Table BIOMARKER TESTING MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: BIOMARKER TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: BIOMARKER TESTING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: BIOMARKER TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • OTHER BIOANALYTICAL TESTING SERVICES
        • Table OTHER BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: OTHER BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: OTHER BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: OTHER BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • DECENTRALIZED CLINICAL TRIAL SERVICES
      • HIGH DEMAND FOR DCT ATTRIBUTED TO ADVANCEMENTS IN DIGITAL HEALTH TECHNOLOGIES
        • Table DECENTRALIZED CLINICAL TRIAL SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: DECENTRALIZED CLINICAL TRIAL SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: DECENTRALIZED CLINICAL TRIAL SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: DECENTRALIZED CLINICAL TRIAL SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • PATIENT RECRUITMENT SERVICES
      • GROWING NEED FOR PATIENT-CENTRIC CLINICAL TRIAL SERVICES TO SUPPORT DEMAND
        • Table OVERVIEW OF PATIENT RECRUITMENT SERVICE PROVIDERS
        • Table PATIENT RECRUITMENT SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PATIENT RECRUITMENT SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PATIENT RECRUITMENT SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PATIENT RECRUITMENT SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • SITE IDENTIFICATION SERVICES
      • INTRODUCTION OF DIGITAL TECHNOLOGIES ENABLING DATA VARIABILITY TO DRIVE MARKET
        • Table SITE IDENTIFICATION SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: SITE IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: SITE IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: SITE IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • ANALYTICAL TESTING SERVICES
      • INCREASING DEMAND FOR ANALYTICAL TESTING IN DRUG DEVELOPMENT TO DRIVE MARKET
        • Table ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • SUPPLY & LOGISTICS SERVICES
      • USAGE OF ADVANCED DATA ANALYTICS IN CLINICAL TRIAL SUPPLY MANAGEMENT TO DRIVE MARKET
        • Table SUPPLY & LOGISTICS SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: SUPPLY & LOGISTICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: SUPPLY & LOGISTICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: SUPPLY & LOGISTICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • PROTOCOL DESIGNING SERVICES
      • NEED FOR PLANNING SUPPORT TO BOOST DEMAND FOR PROTOCOL DESIGN
        • Table PROTOCOL DESIGNING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PROTOCOL DESIGNING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PROTOCOL DESIGNING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PROTOCOL DESIGNING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • DATA MANAGEMENT SERVICES
      • DATA MANAGEMENT SERVICES TO RECORD HIGHEST CAGR OVER FORECAST PERIOD
        • Table DATA MANAGEMENT SERVICES OFFERED BY PROMINENT PLAYERS
        • Table DATA MANAGEMENT SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: DATA MANAGEMENT SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: DATA MANAGEMENT SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: DATA MANAGEMENT SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • MEDICAL DEVICE TESTING SERVICES
      • INCREASING MEDICAL DEVICE R&D TO DRIVE MARKET
        • Table MEDICAL DEVICE TESTING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • OTHER SERVICES
      • Table OTHER CLINICAL TRIAL SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: OTHER CLINICAL TRIAL SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: OTHER CLINICAL TRIAL SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: OTHER CLINICAL TRIAL SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA
    • INTRODUCTION
      • Table CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
    • ONCOLOGY
      • ONCOLOGY TO DOMINATE MARKET DUE TO RISING INCIDENCE OF CANCER
        • Table NEW FDA-APPROVED ONCOLOGY DRUGS (2023)
        • Table CLINICAL TRIALS MARKET FOR ONCOLOGY, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • INFECTIOUS DISEASES
      • INFECTIOUS DISEASES TO HOLD SECOND-LARGEST MARKET SHARE, BY THERAPEUTIC AREA
        • Table CLINICAL TRIALS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
    • NEUROLOGY
      • INCREASING INVESTMENTS IN R&D AND GRANTS FOR NEUROLOGICAL DISORDERS TO DRIVE MARKET
        • Table LIST OF PIPELINE DRUGS FOR NEUROLOGICAL DISORDERS (2020)
        • Table CLINICAL TRIALS MARKET FOR NEUROLOGY, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • METABOLIC DISORDERS
      • RISING DIABETES INCIDENCE TO DRIVE MARKET
        • Table CLINICAL TRIALS MARKET FOR METABOLIC DISORDERS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR METABOLIC DISORDERS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET FOR METABOLIC DISORDERS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR METABOLIC DISORDERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • IMMUNOLOGY
      • GROWING PIPELINE OF IMMUNOLOGICAL DRUGS TO BOOST OUTSOURCING
        • Table LIST OF PIPELINE DRUGS FOR IMMUNOLOGICAL DISORDERS (2022)
        • Table CLINICAL TRIALS MARKET FOR IMMUNOLOGY, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • CARDIOLOGY
      • HIGH MORTALITY RATES TO DRIVE DEVELOPMENT OF NEW TREATMENTS
        • Table LIST OF PIPELINE DRUGS FOR CARDIOVASCULAR DISEASES (2023)
        • Table CLINICAL TRIALS MARKET FOR CARDIOLOGY, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • GENETIC DISEASES
      • GOVERNMENT SUPPORT FOR RARE & GENETIC DISEASE THERAPEUTICS TO BOOST MARKET
        • Table CLINICAL TRIALS MARKET FOR GENETIC DISEASES, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR GENETIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET FOR GENETIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR GENETIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
    • WOMEN’S HEALTH
      • RISING PREVALENCE OF CHRONIC DISORDERS IN WOMEN TO PROPEL DEMAND
        • Table CLINICAL TRIALS MARKET FOR WOMEN’S HEALTH, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR WOMEN’S HEALTH, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET FOR WOMEN’S HEALTH, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR WOMEN’S HEALTH, BY COUNTRY, 2021-2028 (USD MILLION)
    • OTHER THERAPEUTIC AREAS
      • Table LIST OF PIPELINE DRUGS FOR SKIN DISEASES (2022)
      • Table CLINICAL TRIALS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: CLINICAL TRIALS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021-2028 (USD MILLION)
  • CLINICAL TRIALS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • SMALL MOLECULES
      • INVESTMENTS IN SMALL-MOLECULE DEVELOPMENT TO SUPPORT GROWTH
        • Table CLINICAL TRIALS MARKET FOR SMALL MOLECULES, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR SMALL MOLECULES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET FOR SMALL MOLECULES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR SMALL MOLECULES, BY COUNTRY, 2021-2028 (USD MILLION)
    • MONOCLONAL ANTIBODIES
      • GROWING GOVERNMENT SUPPORT FOR MONOCLONAL ANTIBODIES TO DRIVE MARKET
        • Table CLINICAL TRIALS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • VACCINES
      • SHIFTING INDUSTRY FOCUS TOWARD CHRONIC DISEASE TREATMENT TO SLOW MARKET GROWTH
        • Table CLINICAL TRIALS MARKET FOR VACCINES, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR VACCINES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET FOR VACCINES, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR VACCINES, BY COUNTRY, 2021-2028 (USD MILLION)
    • CELL & GENE THERAPY
      • RISING TREND OF OUTSOURCING TO FAVOR MARKET GROWTH
        • Table CLINICAL TRIALS MARKET FOR CELL & GENE THERAPY, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • OTHER APPLICATIONS
      • Table CLINICAL TRIALS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: CLINICAL TRIALS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: CLINICAL TRIALS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: CLINICAL TRIALS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • CLINICAL TRIALS MARKET, BY REGION
    • INTRODUCTION
      • Table CLINICAL TRIALS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • NORTH AMERICA
      • NORTH AMERICA: RECESSION IMPACT
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • US
        • Table US: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table US: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table US: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • CANADA
        • Table CANADA: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table CANADA: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table CANADA: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • EUROPE
      • EUROPE: RECESSION IMPACT
        • Table EUROPE: CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table EUROPE: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • GERMANY
        • Table GERMANY: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table GERMANY: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table GERMANY: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • UK
        • Table UK: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table UK: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table UK: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • FRANCE
        • Table FRANCE: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table FRANCE: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table FRANCE: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • ITALY
        • Table ITALY: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table ITALY: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table ITALY: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • SPAIN
        • Table SPAIN: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table SPAIN: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table SPAIN: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • REST OF EUROPE
        • Table REST OF EUROPE: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • ASIA PACIFIC
      • ASIA PACIFIC: RECESSION IMPACT
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • CHINA
        • Table CHINA: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table CHINA: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table CHINA: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • JAPAN
        • Table JAPAN: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table JAPAN: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table JAPAN: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • INDIA
        • Table INDIA: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table INDIA: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table INDIA: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table REST OF ASIA PACIFIC: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • LATIN AMERICA
      • RISING PHARMA & BIOTECH R&D TO BOOST MARKET GROWTH
      • LATIN AMERICA: RECESSION IMPACT
        • Table LATIN AMERICA: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
      • MIDDLE EAST & AFRICA: RECESSION IMPACT
        • Table MIDDLE EAST & AFRICA: CLINICAL TRIALS MARKET, BY PHASE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CLINICAL TRIALS MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CLINICAL TRIALS MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: CLINICAL TRIALS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • KEY PLAYER STRATEGIES/RIGHT TO WIN
    • REVENUE SHARE ANALYSIS
    • MARKET SHARE ANALYSIS
      • Table CLINICAL TRIALS MARKET: DEGREE OF COMPETITION
    • COMPANY EVALUATION MATRIX, 2022
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
    • COMPANY FOOTPRINT ANALYSIS OF TOP 25 PLAYERS
      • INDUSTRY FOOTPRINT (25 COMPANIES)
        • Table INDUSTRY FOOTPRINT ANALYSIS: KEY PLAYERS
      • SERVICE FOOTPRINT (25 COMPANIES)
        • Table SERVICE FOOTPRINT ANALYSIS: KEY PLAYERS
      • REGIONAL FOOTPRINT (25 COMPANIES)
        • Table REGIONAL FOOTPRINT ANALYSIS: KEY PLAYERS
    • COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
      • PROGRESSIVE COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
    • COMPETITIVE BENCHMARKING OF START-UPS/SMES
      • Table CLINICAL TRIALS MARKET: DETAILED LIST OF KEY START-UPS/SMES
      • Table SERVICE FOOTPRINT ANALYSIS: START-UP/SMES
      • Table REGIONAL FOOTPRINT ANALYSIS: START-UPS/SMES
    • COMPETITIVE SCENARIO AND TRENDS
      • SERVICE LAUNCHES
        • Table CLINICAL TRIALS MARKET: SERVICE LAUNCHES (2020-2023)
      • DEALS
        • Table CLINICAL TRIALS MARKET: DEALS (2020-2023)
      • OTHER DEVELOPMENTS
        • Table CLINICAL TRIALS MARKET: OTHER DEVELOPMENTS (2020-2023)
  • COMPANY PROFILES
    • KEY COMPANIES
      • THERMO FISHER SCIENTIFIC, INC.
        • Table THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
      • IQVIA, INC.
        • Table IQVIA, INC.: BUSINESS OVERVIEW
      • ICON PLC
        • Table ICON PLC: BUSINESS OVERVIEW
      • LABORATORY CORPORATION OF AMERICA HOLDINGS
        • Table LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW
      • SYNEOS HEALTH
        • Table SYNEOS HEALTH: BUSINESS OVERVIEW
      • WUXI APPTEC
        • Table WUXI APPTEC: BUSINESS OVERVIEW
      • CHARLES RIVER LABORATORIES
        • Table CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
      • PAREXEL INTERNATIONAL CORPORATION
        • Table PAREXEL INTERNATIONAL CORPORATION: BUSINESS OVERVIEW
      • FORTREA, INC.
        • Table FORTREA, INC.: BUSINESS OVERVIEW
      • MEDPACE
        • Table MEDPACE: BUSINESS OVERVIEW
      • SGS
        • Table SGS: BUSINESS OVERVIEW
      • FRONTAGE LABS
        • Table FRONTAGE LABS: BUSINESS OVERVIEW
      • ACM GLOBAL LABORATORIES
        • Table ACM GLOBAL LABORATORIES: BUSINESS OVERVIEW
      • ADVANCED CLINICAL
        • Table ADVANCED CLINICAL: BUSINESS OVERVIEW
      • PSI
        • Table PSI: BUSINESS OVERVIEW
      • BIOAGILE
        • Table BIOAGILE: BUSINESS OVERVIEW
    • OTHER PLAYERS
      • CLINICAL TRIAL SERVICE
      • WORLDWIDE CLINICAL TRIALS
      • PEPGRA
      • CTI CLINICAL TRIAL AND CONSULTING SERVICES
      • DOVE QUALITY SOLUTIONS
      • FIRMA CLINICAL RESEARCH
      • CELERION
      • NOVOTECH
      • LINICAL AMERICAS
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
    • CUSTOMIZATION OPTIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings